Replies to post #498305 on Anavex Life Sciences Corp (AVXL)

[xodcode]

This represents a human pharmacogenetic validation of target engagement of blarcamesine in its cognition-preserving effects.

Once again, great post, hnbadger1! Note: "validation of target engagement in its cognision-preserving effects".

AVXL management findings underscore why they are very excited awaiting EMA approval. Not wishy washy in any way about their findings. Time to add on!

Oh, for any naysayers out there, it's pretty obvious that WGT!